ReviewFrontiers in chemistry2026
Exploration of covalent-organic frameworks and metal-organic frameworks for drug delivery applications.
Review in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Covalent-organic frameworks (COFs) and metal-organic frameworks (MOFs) have been a promising carrier for drug delivery because of excellent biocompatibility, developed porous structure and sufficient interactions of host-guest molecules. This paper mainly reviews latest research progress of COFs and MOFs including their synthesis approaches and applications in drug delivery. Specifically, COFs as drug carriers in chemotherapy, photodynamic therapy, photothermal therapy, synergistic therapy, anti-bacteria, and anti-inflammatory were systematically presented. MOFs in pharmaceutical drug delivery, controlled-release drug delivery, stimulus response and targeted drug delivery systems are introduced. The advantages and disadvantages of COFs and MOFs in synthesis and drug delivery performances was systematically compared. The future development trends of COFs and MOFs for drug delivery applications are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.